Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eudesmin shows antiinflammatory, neuritogenic, anticonvulsant and sedative effects, the mechanism of eudesmin may be related to up-regulation of GABAA and GAD65 expressions, and anti-apoptosis of neuron the in brain.50 microM (+)-eudesmin can induce neurite outgrowth and enhance nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 186.00 | |
5 mg | In stock | $ 460.00 | |
10 mg | In stock | $ 676.00 | |
25 mg | In stock | $ 1,060.00 | |
50 mg | In stock | $ 1,430.00 | |
100 mg | In stock | $ 1,930.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 470.00 |
Description | Eudesmin shows antiinflammatory, neuritogenic, anticonvulsant and sedative effects, the mechanism of eudesmin may be related to up-regulation of GABAA and GAD65 expressions, and anti-apoptosis of neuron the in brain.50 microM (+)-eudesmin can induce neurite outgrowth and enhance nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways. |
Source |
Molecular Weight | 386.44 |
Formula | C22H26O6 |
CAS No. | 526-06-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (64.69 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eudesmin 526-06-7 MAPK PI3K/Akt/mTOR signaling S6 Kinase Ribosomal S6 Kinase (RSK) S6K obesity diseases Adipogenesis S6K1 Eudesmine Inhibitor metabolic inhibit inhibitor